YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also man…
Drug Manufacturers - Specialty & Generic
CN, Yichang [HQ]
Acquisitions · S-4
Mergers & Acquisitions
M&A Details · Industry · Urgent
M&A Deals · Breakdown
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has no acquisition track records yet.
M&A Deals · History
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has no acquisition track records yet.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. can't present any M&A detail analysis.
Try it with one of the Urgent M&A Deals by clicking "Details".
Try it with one of the Urgent M&A Deals by clicking "Details".
M&A Deals · Within Industry
Keep an eye on latest M&A deals done inside the Drug Manufacturers—Specialty & Generic Industry.
M&A Deals · Urgent
Act, dont react; Track the most urgent M&A deals across all industries
Details
Details
Details
?
Equity
Agg. Maximum Price
$4,221.65
?
Details
Details
United Bankshares, Inc.
Equity
Agg. Maximum Price
$206,633,909.86
?
Details
Details
Details
Icahn Enterprises L.P.
Debt
Agg. Maximum Price
$700,000,000.00
?
Details
Details
Corebridge Financial, Inc.
Debt
Agg. Maximum Price
$500,000,000.00